ch.oddb.org
  
Fachinformation zu Orfiril®/- long:Desitin Pharma GmbH
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
N03AG01 - Valproic AcidATC-DDD Version 2016. Source: WHO
N - Nervous System
 
N03 - Antiepileptics
 
N03A - Antiepileptics

This group comprises preparations used in the treatment of epilepsy.
Combined preparations are classified at separate 5th levels using the corresponding 50-series.
The group is subdivided according to chemical structure.

The DDDs for the antiepileptics are based on combination therapy.

N03AG - Fatty Acid Derivatives
 
N03AG01 - Valproic Acid
StärkeAdm.RouteNote
 R 
 P 
 O